Page last updated: 2024-09-05

phosphatidylcholines and Deafness, Transitory

phosphatidylcholines has been researched along with Deafness, Transitory in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Devanarayan, P; Devanarayan, V; Issa, LK; Llano, DA	1
Seidman, MD; Vivek, P	1

Reviews

1 review(s) available for phosphatidylcholines and Deafness, Transitory

Article	Year
Intratympanic treatment of hearing loss with novel and traditional agents. Otolaryngologic clinics of North America, 2004, Volume: 37, Issue:5 Topics: Administration, Topical; Animals; Antioxidants; Cysteine Proteinase Inhibitors; Excitatory Amino Acid Antagonists; Genetic Therapy; Glucocorticoids; Glycoproteins; Hearing Loss; Humans; Nerve Growth Factors; Phosphatidylcholines; Round Window, Ear; Tympanic Membrane	2004

Article

Year

Intratympanic treatment of hearing loss with novel and traditional agents.

Otolaryngologic clinics of North America, 2004, Volume: 37, Issue:5

Topics: Administration, Topical; Animals; Antioxidants; Cysteine Proteinase Inhibitors; Excitatory Amino Acid Antagonists; Genetic Therapy; Glucocorticoids; Glycoproteins; Hearing Loss; Humans; Nerve Growth Factors; Phosphatidylcholines; Round Window, Ear; Tympanic Membrane

2004

Trials

1 trial(s) available for phosphatidylcholines and Deafness, Transitory

Article	Year
Hearing Loss in Alzheimer's Disease Is Associated with Altered Serum Lipidomic Biomarker Profiles. Cells, 2020, 11-28, Volume: 9, Issue:12 Topics: Aged; Aging; Alzheimer Disease; Antioxidants; Biomarkers; Female; Hearing Loss; Humans; Lipidomics; Lipids; Male; Phosphatidylcholines; Phosphatidylethanolamines	2020